MENU
HQY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

HQY stock forecast, quote, news & analysis

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions... Show more

A.I.Advisor
published price charts
HQY
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for HQY with price predictions
Oct 27, 2026

HQY's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HQY turned positive on October 05, 2026. Looking at past instances where HQY's MACD turned positive, the stock continued to rise in 43 of 50 cases over the following month. The odds of a continued upward trend are 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 07, 2026. You may want to consider a long position or call options on HQY as a result. In 69 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

HQY moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HQY crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Following a +6.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where HQY advanced for three days, in 223 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 195 of 299 cases where HQY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Bearish Trend Analysis

The 10-day RSI Indicator for HQY moved out of overbought territory on October 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 47 similar instances where the indicator moved out of overbought territory. In 32 of the 47 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HQY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

HQY broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. HQY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 52 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock slightly better than average.

The Tickeron SMR rating for this company is 66 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.193) is normal, around the industry mean (4.353). P/E Ratio (36.029) is within average values for comparable stocks, (13.253). Projected Growth (PEG Ratio) (1.287) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (6.035) is also within normal values, averaging (6.065).

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Teladoc Health (NYSE:TDOC).

Industry description

This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.

Market Cap

The average market capitalization across the Services to the Health Industry Industry is 3.2B. The market cap for tickers in the group ranges from 708 to 50.75B. VEEV holds the highest valuation in this group at 50.75B. The lowest valued company is OTRKQ at 708.

High and low price notable news

The average weekly price growth across all stocks in the Services to the Health Industry Industry was -1%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 18%. SDGR experienced the highest price growth at 14%, while ZCMD experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Services to the Health Industry Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was -13% and the average quarterly volume growth was -58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 53
Price Growth Rating: 55
SMR Rating: 86
Profit Risk Rating: 96
Seasonality Score: -3 (-100 ... +100)
HQY's MACD Histogram just turned positive